Effect of more vs less frequent follow-up testing on overall and colorectal cancer–specific mortality in patients with stage II or III colorectal cancer. The COLOFOL Randomized Clinical Trial. JAMA 2018; 319: 2095-2103.
Published: 9th August 2018
Authors: Wille-Jørgensen P, Syke I, Smedh K, Laurberg S, Nielsen DT, Petersen SH et al.
Compared to low-frequency follow-up, high-frequency follow-up did not improve outcomes in this trial that included 2509 patients. The 5-year cancer-specific mortality rate risk difference was 0.8 per cent, 95 per cent confidence interval -1.7 to 3.3 per cent; P=0.5.Pubmed Link
You may also be interested in
The ALCCaS Trial: a randomized controlled trial comparing quality of life following laparoscopic versus open colectomy for colon cancer. Dis Colon Rectum 2018; 61: 1156-1162.
Authors: McCombie AM, Frizelle F, Bagshaw PF, Frampton CM, Hewett PJ, McMurrick PJ et al.
Enhanced recovery protocols for adults undergoing colorectal surgery. A systematic review and meta-analysis. Dis Colon Rectum 2018; 61: 1108-1118.
Authors: Greer NL, Gunnar WP, Dahm P, Lee AE, MacDonald R, Shaukat A et al.
Ensuring early mobilization within an enhanced recovery program for colorectal surgery: a randomized controlled trial. Ann Surg 2017; 266: 223-231.
Authors: Fiore JF Jr, Castelino T, Pecorelli N, Niculiseanu P, Balvardi S, Hershorn O et al.
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 2017; 389: 1218–1228.
Authors: Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D et al.
Oral and parenteral versus parenteral antibiotic prophylaxis in elective laparoscopic colorectal surgery (JMTO PREV 07–01): a phase 3, multicenter, open-label, randomized trial. Ann Surg 2016; 263: 1085-1091.
Authors: Hata H, Yamaguchi T, Hasegawa S, Nomura A, Hida K, Nishitai R et al.
Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer. The FACS randomized clinical trial. JAMA 2014; 311: 263-270.
Authors: Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A et al. et al.
Authors: Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM et al.
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer : The LARCID Trial. J Clin Oncol 2014; 32: 1006-1011.
Authors: Hoff PM, Saragiotto DF, Barrios H, del Giglio A, Coutinho AK, Andrade AC et al. et al.
Multicentre randomized trial of centralised nurse-led telephone-based care coordination to improve outcomes after surgical resection for colorectal cancer: the CONNECT intervention. J Clin Oncol 2013; 31: 3585–3591.
Authors: Young JM, Butow PN, Walsh J, Durcinoska I, Dobbins TA, Rodwell L et al. et al.
Effects of a telephone-delivered multiple health behavior change intervention (CanChange) on health and behavioral outcomes in survivors of colorectal cancer: a randomized controlled trial. J Clin Oncol 2013; 31: 2313-2321.
Authors: Hawkes AL, Chambers SK, Pakenham KI, Patrao TA, Baade PD, Lynch BM et al. et al.
Questionnaire versus telephone follow-up to detect postdischarge complications in surgical patients: randomized clinical trial. World J Surg 2012; 36: 2576–2583.
Authors: Visser A, Ubbink DT, Gouma DJ, Goslings C
Fast-track surgery improves postoperative clinical recovery and immunity after elective surgery for colorectal carcinoma: a randomized controlled clinical trial. World J Surg 2012; 36: 1874–1880.
Authors: Yang D, He W, Zhang S, Chen H, Zhang C, He Y et al.